Maximum Dose of Olanzapine IV
The maximum single intramuscular dose of olanzapine is 10 mg, and the maximum total daily dose is 30 mg, with injections spaced at least 2 hours apart for the first two doses and 4 hours apart for subsequent doses. 1
Dosing Parameters for IM Olanzapine
Single Dose Maximum
- Standard dose: 10 mg per injection 1
- Lower doses of 5 mg or 7.5 mg may be considered when clinical factors warrant
- Minimum dose of 2.5 mg for debilitated patients or those predisposed to hypotension 1
Maximum Daily Dose
The safety of total daily doses greater than 30 mg has not been evaluated in clinical trials 1. This means:
- Maximum of 3 injections of 10 mg each within 24 hours
- First injection: 10 mg
- Second injection: 10 mg (minimum 2 hours after first dose)
- Third injection: 10 mg (minimum 4 hours after second dose)
Critical Timing Requirements
The FDA label explicitly states that 10 mg injections given more frequently than 2 hours after the initial dose and 4 hours after the second dose have not been evaluated 1. This spacing is crucial because maximal dosing (three 10 mg doses at 2-4 hour intervals) is associated with substantial orthostatic hypotension 1.
Safety Considerations
Orthostatic Hypotension Risk
Patients requiring subsequent intramuscular injections must be assessed for orthostatic hypotension prior to each additional dose 1. The administration of an additional dose to a patient with clinically significant postural change in systolic blood pressure is not recommended 1.
Real-World Safety Data
Recent evidence from 1,214 administrations of IV olanzapine (note: this is off-label IV use, not the approved IM route) showed that doses above 5 mg were associated with significantly higher adverse drug effects (15.23% vs 7.41% overall) 2. While this study examined IV rather than IM administration, it reinforces the importance of dose-related safety concerns.
Special Populations
Geriatric Patients
- 5 mg per injection should be considered 1
Debilitated or Hypotension-Prone Patients
- 2.5 mg per injection should be considered 1
Important Caveats
Route specificity: Olanzapine for injection is intended for intramuscular use only. Do not administer intravenously or subcutaneously 1.
Reconstitution: Must be reconstituted with Sterile Water for Injection only and used within 1 hour 1.
Drug incompatibilities: Do not combine with diazepam (causes precipitation), lorazepam (delays reconstitution), or haloperidol (degrades olanzapine) 1.
Transition to oral: If ongoing therapy is indicated, oral olanzapine may be initiated at 5-20 mg/day as soon as clinically appropriate 1.
Efficacy of repeated doses: While up to 3 doses can be given, the efficacy of repeated doses has not been systematically evaluated in controlled clinical trials 1.
The evidence base for these dosing limits comes from three 24-hour placebo-controlled trials in agitated patients with schizophrenia or bipolar I mania, where efficacy was demonstrated in the 2.5-10 mg dose range 1.